rivastigmine

FDA Drug Profile — Exelon, Rivastigmine

Drug Details

Generic Name
rivastigmine
Brand Names
Exelon, Rivastigmine
Application Number
NDA022083
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
13
Dosage Forms
PATCH, EXTENDED RELEASE, PATCH, POWDER
Routes
TRANSDERMAL
Active Ingredients
RIVASTIGMINE

Indications and Usage

1 INDICATIONS & USAGE Rivastigmine tartrate is an acetylcholinesterase inhibitor indicated for treatment of: • Mild-to-moderate dementia of the Alzheimers type (AD) ( 1.1 ) • Mild-to-moderate dementia associated with Parkinsons disease (PD) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson's Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).